BackPDL Biopharma Overview

PDL Biopharma Other Liabilities

PDL Biopharma's other liabilities is $27M.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$27.37M

Peer average

Loading

PDL Biopharma Other Liabilities History

Loading

PDL Biopharma vs. peers: Other Liabilities Comparison

Loading

PDL Biopharma Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

PDL Biopharma (PDLI) FAQ

The latest other liabilities for PDLI is $27M as of September 2020. In the prior-year period, the figure was $0. Investors often review this figure alongside PDL Biopharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, PDLI's other liabilities moved from $0 to $27M. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in PDL Biopharma's operating scale or balance-sheet position.

A other liabilities figure of $27M for PDLI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PDLI's other liabilities ($27M), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack PDL Biopharma's other liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.